Cargando…
BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
INTRODUCTION: Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores wheth...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861070/ https://www.ncbi.nlm.nih.gov/pubmed/31798997 http://dx.doi.org/10.1136/bmjgh-2019-001862 |
_version_ | 1783471277338525696 |
---|---|
author | Berendsen, Mike LT van Gijzel, Sjors WL Smits, Jeroen de Mast, Quirijn Aaby, Peter Benn, Christine S Netea, Mihai G van der Ven, Andre JAM |
author_facet | Berendsen, Mike LT van Gijzel, Sjors WL Smits, Jeroen de Mast, Quirijn Aaby, Peter Benn, Christine S Netea, Mihai G van der Ven, Andre JAM |
author_sort | Berendsen, Mike LT |
collection | PubMed |
description | INTRODUCTION: Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores whether BCG is associated with protection against malaria in children under the age of 5 years in SSA. METHODS: We used data from the Demographic Health Survey programme, including 34 206 children from 13 SSA countries. BCG status was taken from vaccination cards when present; if not, mother’s recall was used. Presence of malaria was defined as a positive rapid diagnostic test. Maternally reported presence or absence of fever in the previous 2 weeks defined symptomatic status. Multilevel logistic regression was used to account for the two-stage cluster sampling method. RESULTS: Of the 34 206 children, 12 325 (36.0%) children were malaria positive and 29 766 (87.0%) were BCG vaccinated. After correction for relevant child, maternal and household factors, BCG vaccination was associated with a lower malaria prevalence (adjusted OR (aOR)=0.94, 95% CI 0.90 to 0.98), especially among children of whom BCG information was retrieved from a vaccination card (aOR(card)=0.88, 95% CI 0.82 to 0.94). Restricting the analysis to children from regions with suboptimal BCG coverage increased the association (aOR(card)=0.81, 95% CI 0.73 to 0.89). We observed an increasingly beneficial association with each month of age of the child (aOR(card)=0.996, 95% CI 0.993 to 0.999). BCG associations were similar for asymptomatic (aOR(card)=0.86, 95% CI 0.81 to 0.92) and symptomatic (aOR(card)=0.89, 95% CI 0.78 to 1.01) malaria. CONCLUSIONS: BCG vaccination is associated with protection against malaria. This protection is highest in regions with suboptimal BCG coverage. These results indicate a possible role for timely BCG vaccination in the protection of malaria and its elimination by reducing the transmission reservoir. If confirmed in further research, our findings have substantial implications for global efforts to reduce malaria burden. |
format | Online Article Text |
id | pubmed-6861070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-68610702019-12-03 BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa Berendsen, Mike LT van Gijzel, Sjors WL Smits, Jeroen de Mast, Quirijn Aaby, Peter Benn, Christine S Netea, Mihai G van der Ven, Andre JAM BMJ Glob Health Research INTRODUCTION: Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores whether BCG is associated with protection against malaria in children under the age of 5 years in SSA. METHODS: We used data from the Demographic Health Survey programme, including 34 206 children from 13 SSA countries. BCG status was taken from vaccination cards when present; if not, mother’s recall was used. Presence of malaria was defined as a positive rapid diagnostic test. Maternally reported presence or absence of fever in the previous 2 weeks defined symptomatic status. Multilevel logistic regression was used to account for the two-stage cluster sampling method. RESULTS: Of the 34 206 children, 12 325 (36.0%) children were malaria positive and 29 766 (87.0%) were BCG vaccinated. After correction for relevant child, maternal and household factors, BCG vaccination was associated with a lower malaria prevalence (adjusted OR (aOR)=0.94, 95% CI 0.90 to 0.98), especially among children of whom BCG information was retrieved from a vaccination card (aOR(card)=0.88, 95% CI 0.82 to 0.94). Restricting the analysis to children from regions with suboptimal BCG coverage increased the association (aOR(card)=0.81, 95% CI 0.73 to 0.89). We observed an increasingly beneficial association with each month of age of the child (aOR(card)=0.996, 95% CI 0.993 to 0.999). BCG associations were similar for asymptomatic (aOR(card)=0.86, 95% CI 0.81 to 0.92) and symptomatic (aOR(card)=0.89, 95% CI 0.78 to 1.01) malaria. CONCLUSIONS: BCG vaccination is associated with protection against malaria. This protection is highest in regions with suboptimal BCG coverage. These results indicate a possible role for timely BCG vaccination in the protection of malaria and its elimination by reducing the transmission reservoir. If confirmed in further research, our findings have substantial implications for global efforts to reduce malaria burden. BMJ Publishing Group 2019-11-14 /pmc/articles/PMC6861070/ /pubmed/31798997 http://dx.doi.org/10.1136/bmjgh-2019-001862 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Berendsen, Mike LT van Gijzel, Sjors WL Smits, Jeroen de Mast, Quirijn Aaby, Peter Benn, Christine S Netea, Mihai G van der Ven, Andre JAM BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa |
title | BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa |
title_full | BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa |
title_fullStr | BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa |
title_full_unstemmed | BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa |
title_short | BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa |
title_sort | bcg vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-saharan africa |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861070/ https://www.ncbi.nlm.nih.gov/pubmed/31798997 http://dx.doi.org/10.1136/bmjgh-2019-001862 |
work_keys_str_mv | AT berendsenmikelt bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT vangijzelsjorswl bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT smitsjeroen bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT demastquirijn bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT aabypeter bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT bennchristines bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT neteamihaig bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica AT vandervenandrejam bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica |